pAsCpf1(TATV)(BB) (pY221) Citations (1)

Originally described in: Engineered Cpf1 variants with altered PAM specificities.
Gao L, Cox DBT, Yan WX, Manteiga JC, Schneider MW, Yamano T, Nishimasu H, Nureki O, Crosetto N, Zhang F Nat Biotechnol. 2017 Jun 5. doi: 10.1038/nbt.3900. PubMed Journal

---

Articles Citing pAsCpf1(TATV)(BB) (pY221)

Articles
Torsin ATPase deficiency leads to defects in nuclear pore biogenesis and sequestration of MLF2. Rampello AJ, Laudermilch E, Vishnoi N, Prophet SM, Shao L, Zhao C, Lusk CP, Schlieker C. J Cell Biol. 2020 Jun 1;219(6). pii: 151708. doi: 10.1083/jcb.201910185. PubMed

If you have published an article using this material, please email us at to have your article added to this page.